PSI-7409 is the active 5'-triphosphate metabolite of sofosbuvir (PSI-7977), a selective and potent nucleotide analog inhibitor of hepatitis C virus (HCV). It inhibits the enzymatic activities of HCV NS5B polymerases (genotypes 1b, 2a, 3a, and 4a) in a dose-dependent manner, with IC50 values of 1.6 μM, 2.8 μM, 0.7 μM, and 2.6 μM, respectively. PSI-7409 exhibits weak inhibition against DNA polymerase α (IC50 = 550 μM) and shows no inhibition of DNA polymerases β and γ at concentrations up to 1 mM. It is primarily used as an antiviral agent targeting HCV replication through inhibition of the viral RNA-dependent RNA polymerase.